How Has the Sphygmomanometer Market Evolved Historically and What is its Current Size?
The sphygmomanometer market has seen considerable growth due to a variety of factors.
•In the past few years, the sphygmomanometer market has experienced a robust growth. The market value, which stands at $2.98 billion in 2024, is expected to surge to $3.22 billion in 2025, growing at a compound annual growth rate (CAGR) of 8.3%.
Factors contributing to the earlier growth include expansion in the construction industry, increased demand in the agricultural sector, versatility and reach, ongoing infrastructure projects, improved material handling efficiency, and rising demand from the rental market.
What is the Forecasted Market Size and CAGR for the Sphygmomanometer Market?
The sphygmomanometer market is expected to maintain its strong growth trajectory in upcoming years.
• The market for sphygmomanometers is anticipated to experience swift expansion in the forthcoming years, projected to reach "$4.84 billion in 2029 with a compound annual growth rate (CAGR) of 10.7%.
The upswing in this era can be credited to factors such as renewable energy ventures, urban development, and vertical construction, precision farming techniques, emphasis on ecological preservation, compliance with safety protocols, and worldwide economic recovery. Key trends for this prediction period encompass product innovation, compact and easily moveable designs, electric and hybrid models, implementation of telematics and iot, and the employment of robust materials.
What Key Factors and Trends are Driving the Growth of the Sphygmomanometer Market?
The escalating occurrence of chronic diseases like diabetes, hypertension, and ischemic heart disease is predicted to drive the advancement of the sphygmomanometer market in the future. Chronic diseases are enduring health issues that need continuous management and medicinal care. Sphygmomanometers play a crucial role in managing such illnesses and they can also aid in diagnosing and monitoring other cardiovascular issues, besides detecting secondary hypertension causes like renal artery stenosis or pheochromocytoma by observing fluid overload. For example, in December 2022, the Journal of the American College of Cardiology (JACC), a US-based medical journal approved by peers, reported that ischemic heart disease led to 9.44 million cardiovascular deaths in 2021, while diseases like hypertensive heart disease and pulmonary arterial hypertension accounted for 1.41 million and 23,300 deaths respectively. Consequently, the growing occurrence of chronic diseases like diabetes, hypertension, and ischemic heart disease is fueling the expansion of the sphygmomanometer market.
What are the Market Segments in the Sphygmomanometer Market?
The sphygmomanometer market covered in this report is segmented –
1) By Product: Electronic Sphygmomanometer, Aneroid Sphygmomanometer, Mercury Sphygmomanometer
2) By Configuration: Portable, Desk Mounted, Floor Standing, Wall Mounted
3) By Operation: Electric, Manual, Automatic, Semi-automatic
4) By End User: Hospitals, Ambulatory Surgical Centers And Clinics, Home Healthcare, Other End Users
Subsegments:
1) By Electronic Sphygmomanometer: Upper Arm Electronic Sphygmomanometer, Wrist Electronic Sphygmomanometer, Finger Electronic Sphygmomanometer
2) By Aneroid Sphygmomanometer: Manual Aneroid Sphygmomanometer, Digital Aneroid Sphygmomanometer
3) By Mercury Sphygmomanometer: Standard Mercury Sphygmomanometer, Portable Mercury Sphygmomanometer
Pre-Book The Sphygmomanometer Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends are Shaping the Sphygmomanometer Market?
Key sphygmomanometer market players are concentrating on creating groundbreaking products like automatic blood pressure monitors in efforts to improve accuracy, enrich user experience, and enable constant blood pressure monitoring for efficient hypertension and heart health management. These automatic monitors are electronic tools that use an inflatable cuff and oscillometric technology to provide precise measurements of systolic and diastolic pressures and pulse rate, aiding easy self-monitoring at home. For example, InBody, a company from South Korea renowned for delivering body composition technology, introduced the BP 170 in February 2022. This automatic blood pressure monitor, geared towards home use, employs oscillometric technology to give accurate readings of systolic and diastolic blood pressure, as well as the pulse rate. The BP 170 comes with an easy-to-use one-touch cuff, a large screen for better visibility, and the ability to save multiple users' readings, which makes it perfect for family health tracking. Furthermore, its clinical validation assures reliable results that can help users effectively control their heart health.
Who Are the Key Players in the Sphygmomanometer Market?
Major companies operating in the sphygmomanometer market include:
• A&D Company Ltd.
• American Diagnostic Corporation
• Omron Healthcare Inc.
• Microlife Corporation
• Acoma Medical Industry Co. Ltd.
• Beurer GmbH
• General Electric Company
• Amico Group of Companies
• CIGA Healthcare Ltd.
• HEINE Optotechnik GmbH and Co. KG
• Rossmax International Ltd.
• Rudolf Riester GmbH
• Welch Allyn Inc.
• Koninklijke Philips N.V.
• Paul Hartmann AG
• 3B Scientific
• Hill-Rom Services Inc.
• Sklar Surgical Instruments
• Spengler
• Holtex Ltd.
• Timesco Healthcare Ltd.
• Bremed Ltd.
• iHealth Labs Inc.
• Contec Medical Systems Co. Ltd.
• Halma plc
• SunTech Medical Inc.
What are the Regional Insights into the Sphygmomanometer Market?
North America was the largest region in the sphygmomanometer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global sphygmomanometer market during the forecast period. The regions covered in the sphygmomanometer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
